GRITSTONE BIO INC
GRITSTONE BIO INC
Share · US39868T1051 · GRTS · A2N4RX (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % -95,91 % -99,53 %

Company Profile for GRITSTONE BIO INC Share

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Company Data

Name GRITSTONE BIO INC
Company Gritstone bio, Inc.
Symbol GRTS
Website https://gritstonebio.com
Primary Exchange XNAS NASDAQ
WKN A2N4RX
ISIN US39868T1051
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Country United States of America
Currency USD
Employees 0,2 T
Address 5959 Horton Street, 94608 EmeryVille
IPO Date 2018-09-28

Ticker Symbols

Name Symbol
Frankfurt 2JQ.F
NASDAQ GRTS

More Shares

Investors who GRITSTONE BIO INC hold also have the following shares in their portfolio:
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
BAIDU INC - ADR
BAIDU INC - ADR Share
CEMATRIX CORP
CEMATRIX CORP Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
DEUTSCHE TELEKOM AG
DEUTSCHE TELEKOM AG Share
HCO        RZ 1 14/23
HCO RZ 1 14/23 Bond
INFINEON TECHNOLOGIESLOGIES AG
INFINEON TECHNOLOGIESLOGIES AG Share
JD.CO INC - ADR
JD.CO INC - ADR Share
MERCEDES BENZ GROUP AG
MERCEDES BENZ GROUP AG Share
MICROSOFT CORP
MICROSOFT CORP Share
ROB.BOSCH FI 25/31
ROB.BOSCH FI 25/31 Bond
SKYWORKS SOLUTIONS INC
SKYWORKS SOLUTIONS INC Share
T(L)-EUR.SM.CO.1EP EOD
T(L)-EUR.SM.CO.1EP EOD Fund
VARTA AG
VARTA AG Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025